Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
Condition(s):Recurrent Thyroid CancerLast Updated:May 31, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Recurrent Thyroid CancerLast Updated:May 31, 2023Recruiting
Condition(s):Prostate Cancer; 18F- Fluorocholine; PSMA PET; Radiotherapy; Prostatectomy; Tumor of ProstateLast Updated:November 18, 2022Not yet recruiting
Condition(s):Metastatic Clear Cell Renal Cell CarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Prostate CancerLast Updated:September 22, 2023Recruiting
Condition(s):Age Related Macular DegenerationLast Updated:February 8, 2023Recruiting
Condition(s):NeuroblastomaLast Updated:February 15, 2024Recruiting
Condition(s):Cancer of Unknown Primary SiteLast Updated:March 31, 2023Recruiting
Condition(s):Alzheimer DiseaseLast Updated:November 7, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:February 15, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:January 31, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.